O13024 (INCEA_XENLA) Xenopus laevis (African clawed frog)
Inner centromere protein A UniProtKBInterProInteractive Modelling
873 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
12 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal structure of Aurora B in complex with AMP-PNP |
Heteromer Q6DE08; | 1×ANP; | ||||
| Assess | ||||||
| Aurora B kinase in complex with the specific inhibitor Barasertib |
Heteromer Q6DE08; | 1×YJA; | ||||
| Assess | ||||||
| Crystal structure of Aurora B kinase in complex with a aminothiazole inhibitor |
Heteromer Q6DE08; | 1×AD6; | ||||
| Assess | ||||||
| Crystal structure of Aurora B kinase in complex with Reversine inhibitor |
Heteromer Q6DE08; | 1×AD5; | ||||
| Assess | ||||||
| Mechanism of Aurora-B activation by INCENP and inhibition by Hesperadin. |
Heteromer Q6DE08; | |||||
| Assess | ||||||
| Aurora B kinase in complex with VX-680 |
Heteromer Q6DE08; | 1×VX6; | ||||
| Assess | ||||||
| Structure of Aurora B kinase in complex with ZM447439 |
Heteromer Q6DE08; | 1×447; | ||||
| Assess | ||||||
| Aurora kinase selective inhibitors identified using a Taxol-induced checkpoint sensitivity screen. |
Heteromer Q6DE08; | 1×ZTX; | ||||
| Assess | ||||||
| Aurora B kinase P353G mutant |
Heteromer Q6DE08; | 1×A0P; | ||||
| Assess | ||||||
| Crystal structure of AuroraB/INCENP in complex with BI 811283 |
Heteromer Q6DE08; | 1×6Q4; | ||||
| Assess | ||||||
| Complex of Aurora-B with INCENP and Hesperadin. |
Heteromer Q6DE08; | 1×H1N; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF AURORA B IN COMPLEX WITH BI 847325 |
Heteromer Q6DE08; | 1×5U5; | ||||
| Assess | ||||||
3 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8snb.59.A | monomer | 0.71 | 23.08 | |||
| Assess | ||||||
| 6yih.1.C | monomer | 0.60 | 56.00 | |||
| Assess | ||||||
| 4c2w.1.B | monomer | 0.54 | 100.00 | |||
| Assess | ||||||